KR102391761B1 - 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 - Google Patents

탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 Download PDF

Info

Publication number
KR102391761B1
KR102391761B1 KR1020177000765A KR20177000765A KR102391761B1 KR 102391761 B1 KR102391761 B1 KR 102391761B1 KR 1020177000765 A KR1020177000765 A KR 1020177000765A KR 20177000765 A KR20177000765 A KR 20177000765A KR 102391761 B1 KR102391761 B1 KR 102391761B1
Authority
KR
South Korea
Prior art keywords
delete delete
lumen
silicone
drug
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177000765A
Other languages
English (en)
Korean (ko)
Other versions
KR20170026465A (ko
Inventor
희진 이
카렌 다니엘
Original Assignee
타리스 바이오메디컬 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 타리스 바이오메디컬 엘엘씨 filed Critical 타리스 바이오메디컬 엘엘씨
Priority to KR1020227013799A priority Critical patent/KR102486216B1/ko
Priority to KR1020227013798A priority patent/KR20220061253A/ko
Publication of KR20170026465A publication Critical patent/KR20170026465A/ko
Application granted granted Critical
Publication of KR102391761B1 publication Critical patent/KR102391761B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0009—Making of catheters or other medical or surgical tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00—Methods of manufacture, assembly or production
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1078—Urinary tract
    • A61M2210/1085—Bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
KR1020177000765A 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 Active KR102391761B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020227013799A KR102486216B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020227013798A KR20220061253A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462017775P 2014-06-26 2014-06-26
US62/017,775 2014-06-26
PCT/US2015/037887 WO2015200752A1 (en) 2014-06-26 2015-06-26 Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1020227013798A Division KR20220061253A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020227013799A Division KR102486216B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법

Publications (2)

Publication Number Publication Date
KR20170026465A KR20170026465A (ko) 2017-03-08
KR102391761B1 true KR102391761B1 (ko) 2022-04-27

Family

ID=53524992

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020177000765A Active KR102391761B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020227013799A Active KR102486216B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020237033481A Pending KR20230142816A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020227013798A Ceased KR20220061253A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020227013799A Active KR102486216B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020237033481A Pending KR20230142816A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020227013798A Ceased KR20220061253A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법

Country Status (9)

Country Link
US (3) US10737078B2 (cg-RX-API-DMAC7.html)
EP (3) EP4173615A3 (cg-RX-API-DMAC7.html)
JP (3) JP6856380B2 (cg-RX-API-DMAC7.html)
KR (4) KR102391761B1 (cg-RX-API-DMAC7.html)
CN (2) CN106456951B (cg-RX-API-DMAC7.html)
AU (5) AU2015279674B2 (cg-RX-API-DMAC7.html)
DK (1) DK3160442T3 (cg-RX-API-DMAC7.html)
ES (2) ES2940478T3 (cg-RX-API-DMAC7.html)
WO (1) WO2015200752A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150250717A1 (en) 2014-03-06 2015-09-10 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder cancer with gemcitabine
US20180117219A1 (en) * 2015-04-29 2018-05-03 Northwestern University 3d printing of biomedical implants
US11185670B2 (en) 2016-01-26 2021-11-30 Taris Biomedical Llc Multi-lumen drug delivery devices
SMT202300047T1 (it) 2016-05-06 2023-03-17 Taris Biomedical Llc Metodo di trattamento del cancro uroteliale del tratto inferiore
US10857173B2 (en) 2017-07-25 2020-12-08 Taris Biomedical Llc Methods of treating tumor metastasis
JOP20200124A1 (ar) 2017-11-08 2020-05-20 Taris Biomedical Llc طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك
WO2019232291A1 (en) * 2018-05-31 2019-12-05 Massachusetts Institute Of Technology Drug delivery articles for gram-level dosing
KR20210039403A (ko) 2018-08-01 2021-04-09 타리스 바이오메디컬 엘엘씨 트로스피움을 사용한 과민성 방광의 치료 방법
EP4789707A2 (en) * 2018-11-09 2026-08-12 Janssen Biotech, Inc. Drug delivery devices, systems, and methods for local drug delivery to the upper urinary tract
CN116456982A (zh) * 2020-09-28 2023-07-18 加利福尼亚大学董事会 包含阿帕鲁胺的药物植入物及其使用方法
AU2022418527A1 (en) 2021-12-21 2024-08-08 Taris Biomedical Llc Urinary placement catheter for intravesical devices
CN115120854B (zh) * 2022-07-04 2023-10-13 奥格生物技术（六安）有限公司 前列腺自然直接给药装置
JP2025524816A (ja) * 2022-07-20 2025-08-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ダロルタミドを含有する薬物インプラント及びその使用方法
WO2024092159A1 (en) 2022-10-28 2024-05-02 Taris Biomedical Llc Methods of treating bladder cancer with gemcitabine
KR20250168664A (ko) 2023-04-10 2025-12-02 타리스 바이오메디컬 엘엘씨 바실루스 칼메트-구에린 요법에 무반응성인 고위험 근육 비침습성 방광암을 치료하는 방법에 사용하기 위한 젬시타빈
TW202532086A (zh) 2023-10-02 2025-08-16 美商塔里斯生物醫學有限責任公司 治療對卡介苗療法無反應之高風險非肌肉侵襲性膀胱癌之方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012048104A1 (en) * 2010-10-06 2012-04-12 Taris Biomedical, Inc. Implantable drug delivery device with bladden retention feature

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US4871542A (en) 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
NZ228382A (en) * 1989-03-17 1992-08-26 Carter Holt Harvey Plastic Pro Drug administering coil-like device for insertion in body cavity of animal
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
US20070161968A1 (en) * 1996-06-04 2007-07-12 Vance Products Inc., Dba Cood Urological Inc. Implantable medical device with pharmacologically active ingredient
US20060025726A1 (en) * 1996-06-04 2006-02-02 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with pharmacologically active layer
US20060052757A1 (en) * 1996-06-04 2006-03-09 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with analgesic or anesthetic
AU6876498A (en) 1997-04-03 1998-10-22 Point Biomedical Corporation Intravesical drug delivery system
US6183461B1 (en) 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
US6752829B2 (en) 2001-01-30 2004-06-22 Scimed Life Systems, Inc. Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same
MX2013000002A (es) 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
US8685427B2 (en) * 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US7166133B2 (en) * 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
DE10247689A1 (de) 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
US6926735B2 (en) 2002-12-23 2005-08-09 Scimed Life Systems, Inc. Multi-lumen vascular grafts having improved self-sealing properties
US7288084B2 (en) * 2003-04-28 2007-10-30 Boston Scientific Scimed, Inc. Drug-loaded medical device
JP5265359B2 (ja) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
US20080311172A1 (en) * 2007-04-25 2008-12-18 Schapira Jay N Programmed-release, nanostructured biological construct
US9586035B2 (en) * 2007-12-11 2017-03-07 Massachusetts Institute Of Technology Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
AU2010265863C1 (en) 2009-06-26 2012-11-01 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
AU2010339821B2 (en) * 2009-12-17 2015-02-19 Taris Biomedical Llc Implantable device with intravesical tolerability and methods of treatment
SMT202000670T1 (it) 2010-08-05 2021-01-05 Taris Biomedical Llc Dispositivo e kit di somministrazione di farmaci per stent ureterale
EP3711750B1 (en) 2010-08-05 2023-09-06 TARIS Biomedical LLC Implantable drug delivery devices for genitourinary sites
JP5945544B2 (ja) * 2010-10-06 2016-07-05 タリス バイオメディカル エルエルシー 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法
RU2598057C2 (ru) 2011-02-04 2016-09-20 ТАРИС Биомедикал ЛЛК Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью
US20140209100A1 (en) * 2011-07-20 2014-07-31 Patrick F. Kiser Intravaginal devices for drug delivery
US10058688B2 (en) 2012-05-09 2018-08-28 Massachusetts Institute Of Technology Medicament, method, and drug delivery device for treatment of ovarian cancer
KR102246491B1 (ko) * 2012-05-19 2021-04-29 타리스 바이오메디컬 엘엘씨 개선된 회수 특징을 갖는 주입가능한 비뇨기 장치
HUE072250T2 (hu) 2013-03-15 2025-11-28 Taris Biomedical Llc Gyógyszeradagoló eszközök gyógyszeráteresztõ résszel
US9814671B2 (en) 2013-03-15 2017-11-14 Taris Biomedical Llc Drug delivery devices and methods for drug delivery
ES2956840T3 (es) 2013-08-19 2023-12-29 Taris Biomedical Llc Dispositivos de administración de fármacos de múltiples unidades
PL3142740T3 (pl) 2014-05-12 2021-06-14 Taris Biomedical Llc Urządzenia do dostarczania leku
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012048104A1 (en) * 2010-10-06 2012-04-12 Taris Biomedical, Inc. Implantable drug delivery device with bladden retention feature

Also Published As

Publication number Publication date
EP3160442B1 (en) 2019-03-06
AU2024204468A1 (en) 2024-07-18
JP2020110615A (ja) 2020-07-27
AU2020250209A1 (en) 2020-11-05
US11904123B2 (en) 2024-02-20
ES2728504T3 (es) 2019-10-25
AU2026203471A1 (en) 2026-05-21
CN114306899A (zh) 2022-04-12
AU2022204523A1 (en) 2022-07-21
US20200368509A1 (en) 2020-11-26
KR20230142816A (ko) 2023-10-11
JP7005668B2 (ja) 2022-01-21
JP6856380B2 (ja) 2021-04-07
KR20170026465A (ko) 2017-03-08
US20200368508A1 (en) 2020-11-26
CN106456951A (zh) 2017-02-22
AU2015279674A1 (en) 2017-01-12
US10737078B2 (en) 2020-08-11
EP4173615A3 (en) 2023-07-19
WO2015200752A8 (en) 2016-08-11
AU2024204468B2 (en) 2026-02-26
JP2017524421A (ja) 2017-08-31
KR20220061253A (ko) 2022-05-12
AU2020250209B2 (en) 2022-07-14
US20170165460A1 (en) 2017-06-15
ES2940478T3 (es) 2023-05-08
AU2015279674B2 (en) 2020-07-23
AU2022204523B2 (en) 2024-05-16
DK3160442T3 (da) 2019-06-11
KR102486216B1 (ko) 2023-01-09
EP4173615A2 (en) 2023-05-03
US12239807B2 (en) 2025-03-04
EP3517099B1 (en) 2022-12-28
EP3160442A1 (en) 2017-05-03
JP2022022292A (ja) 2022-02-03
WO2015200752A1 (en) 2015-12-30
KR20220061254A (ko) 2022-05-12
CN106456951B (zh) 2021-11-05
EP3517099A1 (en) 2019-07-31

Similar Documents

Publication Publication Date Title
AU2022204523B2 (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
KR102557326B1 (ko) 약물-투과성 구성요소를 가지는 약물 전달 장치
JP2024028930A (ja) 薬物透過性構成要素を有する薬物送達デバイス及び方法
US10933170B2 (en) Drug delivery devices and methods
US20150360012A1 (en) Drug delivery devices and methods for controlled drug release through device orifice
KR20200087147A (ko) 도뇨 카테터와 함께 사용하기 위한 약물 전달 장치 및 방법
HK40092575A (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
US20170246437A1 (en) pH-MODULATING DRUG DELIVERY DEVICES AND METHODS
HK40072987A (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 5